| Database ID | Agent | Target | Cancer Type | Detail |
| DB00166 | BMS936558 | PD1 | advanced solid tumors | view |
| DB00167 | nivolumab | PD1 | non small cell lung cancer | view |
| DB00168 | nivolumab | PD1 | non small cell lung cancer | view |
| DB00169 | nivolumab | PD1 | non small cell lung cancer | view |
| DB00170 | nivolumab | PD1 | non small cell lung cancer | view |
| DB00171 | CF102 | A(3) adenosine receptor | liver cancer | view |
| DB00172 | bavituximab | membrane phospholipid phosphatidylserine (PS) | advanced solid tumors | view |
| DB00173 | bavituximab | membrane phospholipid phosphatidylserine (PS) | non small cell lung cancer | view |
| DB00174 | vemurafenib | BRaf protooncogene
serine/threonineprotein kinase | melanoma | view |
| DB00175 | vemurafenib | BRaf protooncogene
serine/threonineprotein kinase | melanoma | view |
| DB00176 | vemurafenib | BRaf protooncogene
serine/threonineprotein kinase | melanoma | view |
| DB00177 | vemurafenib | BRaf protooncogene
serine/threonineprotein kinase | melanoma | view |
| DB00178 | vemurafenib | BRaf protooncogene
serine/threonineprotein kinase | melanoma | view |
| DB00179 | GSK2118436 | BRaf protooncogene
serine/threonineprotein kinase | melanoma | view |
| DB00180 | dabrafenib | BRaf protooncogene serine/threonineprotein kinase | melanoma | view |